Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24730443 | 0.83 | PDK2 (0.33) | MEN1MAPTKMT2ANPSR1SLC6A3 | |
| SCHEMBL26014168 | 0.82 | MGLL (0.36) | CA1CA2MEN1MAPTKMT2A | |
| SCHEMBL14681416 | 0.74 | CA1 (0.44) | CA1CA2MEN1MAPTKMT2A | |
| SCHEMBL29364815 | 0.74 | CA1 (0.44) | CA1CA2MEN1MAPTKMT2A | |
| SCHEMBL20175791 | 0.74 | CA1 (0.44) | CA1CA2SLC6A3ALDH1A1ENPP2 | |
| SCHEMBL19683804 | 0.73 | PDK2 (0.37) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL30218966 | 0.73 | PDK2 (0.37) | MEN1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL18680187 | 0.73 | CA1 (0.42) | CA1CA2MEN1MAPTKMT2A | |
| SCHEMBL20737530 | 0.73 | CA1 (0.46) | CA1CA2MAPTALDH1A1DHFR | |
| SCHEMBL26014248 | 0.72 | ALDH1A1 (0.42) | CA1CA2MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257387-A1 | ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | OCIAD1, OCIAD2, EPCAM | CA1 4236/4885CA2 4122/4885MEN1 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.